scPharmaceuticals Inc.
SCPH
Cena:
Valuace
70
Růst
23
Zdraví
75
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
SCPHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF SCPHARMACEUTICALS INC. - SCPH
16-09-2025
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, ...
Více zde
SCPHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF SCPHARMACEUTICALS INC. - SCPH
26-08-2025
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ...
Více zde
SHAREHOLDER INVESTIGATION: HALPER SADEH LLC INVESTIGATES VTLE AND SCPH ON BEHALF OF SHAREHOLDERS
26-08-2025
NEW YORK, AUG. 26, 2025 (GLOBE NEWSWIRE) -- HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVEST...
Více zde
SCPH ALERT: MONSEY FIRM OF WOHL & FRUCHTER INVESTIGATING FAIRNESS OF THE SALE OF SCPHARMACEUTICALS TO MANNKIND
25-08-2025
MONSEY, N.Y., AUG. 25, 2025 (GLOBE NEWSWIRE) -- THE LAW FIRM OF WOHL & FRUCHTER LLP IS INVESTIGATING...
Více zde
SCPH STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF SCPHARMACEUTICALS INC. IS FAIR TO SHAREHOLDERS
25-08-2025
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER T...
Více zde
SHAREHOLDER ALERT: THE ADEMI FIRM INVESTIGATES WHETHER SCPHARMACEUTICALS INC. IS OBTAINING A FAIR PRICE FOR ITS PUBLIC SHAREHOLDERS
25-08-2025
MILWAUKEE--(BUSINESS WIRE)--THE ADEMI FIRM IS INVESTIGATING SCPHARMACEUTICALS (NASDAQ: SCPH) FOR POS...
Více zde
MANNKIND TO ACQUIRE SCPHARMACEUTICALS, ACCELERATING REVENUE GROWTH AND EMERGING AS A PATIENT-CENTRIC LEADER IN CARDIOMETABOLIC AND LUNG DISEASES
25-08-2025
DANBURY, CONN. AND BURLINGTON, MASS., AUG. 25, 2025 (GLOBE NEWSWIRE) -- MANNKIND CORPORATION (NASDAQ...
Více zde
SCPHARMACEUTICALS RECEIVES NOTICE OF ALLOWANCES OF MULTIPLE US PATENT APPLICATIONS COVERING SCP-111
14-08-2025
BURLINGTON, MASS., AUG. 14, 2025 (GLOBE NEWSWIRE) -- SCPHARMACEUTICALS INC. (NASDAQ: SCPH) (THE “C...
Více zde
SCPHARMACEUTICALS INC. REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
07-08-2025
GENERATED NET FUROSCIX ® REVENUE OF $16 MILLION IN THE SECOND QUARTER OF 2025; UP 99% OVER Q2 2024...
Více zde
SCPHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2025 FINANCIAL RESULTS AFTER THE MARKET CLOSE ON AUGUST 7, 2025
31-07-2025
BURLINGTON, MASS., JULY 31, 2025 (GLOBE NEWSWIRE) -- SCPHARMACEUTICALS INC. (NASDAQ: SCPH), A PHARMA...
Více zde
SCPHARMACEUTICALS INC. REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
14-05-2025
GENERATED NET FUROSCIX ® REVENUE OF $11.8 MILLION IN THE FIRST QUARTER OF 2025 FORMALLY LAUNCHED FU...
Více zde
SCPHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2025 FINANCIAL RESULTS AFTER THE MARKET CLOSE ON MAY 14, 2025
07-05-2025
MANAGEMENT TO HOST CONFERENCE CALL AND WEBCAST, AFTER-MARKET ON MAY 14, 2025, AT 4:30 P.M. ET MANAGE...
Více zde
SCPHARMACEUTICALS ANNOUNCES PARTICIPATION IN THREE UPCOMING INVESTOR CONFERENCES
01-05-2025
BURLINGTON, MASS., MAY 01, 2025 (GLOBE NEWSWIRE) -- SCPHARMACEUTICALS INC. (NASDAQ: SCPH) (THE “CO...
Více zde
SCPHARMACEUTICALS INC. REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
19-03-2025
SCPHARMACEUTICALS GENERATED FOURTH QUARTER 2024 NET FUROSCIX ® REVENUE OF $12.2 MILLION, AND FULL Y...
Více zde
SCPHARMACEUTICALS TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS ON WEDNESDAY, MARCH 19, 2025
12-03-2025
MANAGEMENT TO HOST CONFERENCE CALL AND WEBCAST, AFTER-MARKET ON MARCH 19, 2025, AT 4:30 P.M. ET MANA...
Více zde
SCPHARMACEUTICALS ANNOUNCES FDA APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION EXPANDING THE FUROSCIX® INDICATION TO INCLUDE THE TREATMENT OF EDEMA IN PATIENTS WITH CHRONIC KIDNEY DISEASE
06-03-2025
FDA APPROVES SCPHARMACEUTICALS' SUPPLEMENTAL NEW DRUG APPLICATION TO EXPAND THE FUROSCIX INDICATION ...
Více zde
SCPHARMACEUTICALS ANNOUNCES PARTICIPATION IN TWO UPCOMING INVESTOR CONFERENCES
26-02-2025
BURLINGTON, MASS., FEB. 26, 2025 (GLOBE NEWSWIRE) -- SCPHARMACEUTICALS INC. (NASDAQ: SCPH) (THE “C...
Více zde
SCPHARMACEUTICALS TO PRESENT AT THE OPPENHEIMER 35TH ANNUAL HEALTHCARE LIFE SCIENCES CONFERENCE
05-02-2025
BURLINGTON, MASS., FEB. 05, 2025 (GLOBE NEWSWIRE) -- SCPHARMACEUTICALS INC. (NASDAQ: SCPH) (THE “C...
Více zde
SCPHARMACEUTICALS PROVIDES PRELIMINARY UNAUDITED FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
10-01-2025
PRELIMINARY UNAUDITED FOURTH QUARTER 2024 NET REVENUE EXPECTED TO BE APPROXIMATELY $12 MILLION TO $1...
Více zde
SCPHARMACEUTICALS INC. REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
13-11-2024
GENERATED 3Q 2024 NET FUROSCIX ® REVENUE OF $10.0 MILLION, UP 164% FROM Q3 2023 RECEIVED APPROVAL O...
Více zde
SCPHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2024 FINANCIAL RESULTS ON WEDNESDAY, NOVEMBER 13, 2024
06-11-2024
MANAGEMENT TO HOST CONFERENCE CALL AND WEBCAST, AFTER-MARKET ON NOVEMBER 13, 2024, AT 4:30 P.M. ET M...
Více zde
SCPHARMACEUTICALS TO HOST KEY OPINION LEADER (KOL) WEBINAR ON OCTOBER 22, 2024
15-10-2024
WEBINAR TO FOCUS ON A NEPHROLOGIST'S PERSPECTIVE ON THE USE OF FUROSCIX FOR FLUID OVERLOAD IN HEART ...
Více zde
SCPHARMACEUTICALS INC. REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
14-08-2024
GENERATED 2Q 2024 NET FUROSCIX® REVENUE OF $8.1 MILLION, UP 33% SEQUENTIALLY FROM Q1 COMPLETED FINA...
Více zde
SCPHARMACEUTICALS ANNOUNCES PRICING OF $50.0 MILLION PUBLIC OFFERING
12-08-2024
BURLINGTON, MASS., AUG. 12, 2024 (GLOBE NEWSWIRE) -- SCPHARMACEUTICALS INC. (NASDAQ: SCPH), A PHARMA...
Více zde
SCPHARMACEUTICALS ANNOUNCES NON-DILUTIVE FINANCINGS TOTALING UP TO $125 MILLION WITH PERCEPTIVE ADVISORS
12-08-2024
SCPHARMACEUTICALS RECEIVED $75 MILLION THROUGH A COMBINATION OF DEBT AND ROYALTY FINANCINGS AT CLOSE...
Více zde
SCPHARMACEUTICALS ANNOUNCES FDA APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION EXPANDING THE FUROSCIX INDICATION IN HEART FAILURE
12-08-2024
FUROSCIX IS NOW INDICATED FOR THE TREATMENT OF CONGESTION DUE TO FLUID OVERLOAD IN ADULT PATIENTS WI...
Více zde
SCPHARMACEUTICALS ANNOUNCES POSITIVE TOPLINE STUDY RESULTS FOR SCP-111 (FUROSEMIDE 80 MG/1 ML) AUTOINJECTOR
12-08-2024
SCP-111 AUTOINJECTOR ACHIEVED PRIMARY PHARMACOKINETIC AND SECONDARY PHARMACODYNAMIC ENDPOINTS THE AU...
Více zde
SCPHARMACEUTICALS ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS
12-08-2024
BURLINGTON, MASS., AUG. 12, 2024 (GLOBE NEWSWIRE) -- SCPHARMACEUTICALS INC. (NASDAQ: SCPH) (THE “C...
Více zde
SCPHARMACEUTICALS TO PRESENT AT THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE
29-05-2024
BURLINGTON, MASS., MAY 29, 2024 (GLOBE NEWSWIRE) -- SCPHARMACEUTICALS INC. (NASDAQ: SCPH), A PHARMAC...
Více zde
SCPHARMACEUTICALS INC. REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
14-05-2024
GENERATED 1Q 2024 NET FUROSCIX® REVENUE OF $6.1 MILLION, DESPITE AN ESTIMATED 10% IMPACT TO DOSES F...
Více zde
| Datum | Typ | Otevřít EDGAR | Stáhnout dokument |
|---|---|---|---|
| 2025-10-07 01:00:00 | 8-K | Stáhnout | |
| 2025-10-07 00:00:00 | 8-K | Stáhnout | |
| 2025-09-24 01:00:00 | 8-K | Stáhnout | |
| 2025-09-24 00:00:00 | 8-K | Stáhnout | |
| 2025-08-25 01:00:00 | 8-K | Stáhnout | |
| 2025-08-25 00:00:00 | 8-K | Stáhnout | |
| 2025-08-07 01:00:00 | 8-K | Stáhnout | |
| 2025-08-07 01:00:00 | 10-Q | Stáhnout | |
| 2025-08-07 00:00:00 | 8-K | Stáhnout | |
| 2025-08-07 00:00:00 | 10-Q | Stáhnout | |
| 2025-06-09 01:00:00 | 8-K | Stáhnout | |
| 2025-06-09 00:00:00 | 8-K | Stáhnout | |
| 2025-05-14 01:00:00 | 8-K | Stáhnout | |
| 2025-05-14 01:00:00 | 10-Q | Stáhnout | |
| 2025-05-14 00:00:00 | 8-K | Stáhnout | |
| 2025-05-14 00:00:00 | 10-Q | Stáhnout | |
| 2025-03-19 00:00:00 | 8-K | Stáhnout | |
| 2025-03-19 00:00:00 | 10-K | Stáhnout | |
| 2025-03-18 23:00:00 | 8-K | Stáhnout | |
| 2025-03-18 23:00:00 | 10-K | Stáhnout | |
| 2025-01-10 00:00:00 | 8-K | Stáhnout | |
| 2025-01-09 23:00:00 | 8-K | Stáhnout | |
| 2024-12-11 00:00:00 | 8-K | Stáhnout | |
| 2024-12-10 23:00:00 | 8-K | Stáhnout | |
| 2024-11-13 00:00:00 | 8-K | Stáhnout | |
| 2024-11-13 00:00:00 | 10-Q | Stáhnout | |
| 2024-11-12 23:00:00 | 8-K | Stáhnout | |
| 2024-11-12 23:00:00 | 10-Q | Stáhnout | |
| 2024-08-14 01:00:00 | 8-K | Stáhnout | |
| 2024-08-14 01:00:00 | 10-Q | Stáhnout | |
| 2024-08-14 00:00:00 | 8-K | Stáhnout | |
| 2024-08-14 00:00:00 | 10-Q | Stáhnout | |
| 2024-08-13 01:00:00 | 8-K | Stáhnout | |
| 2024-08-13 00:00:00 | 8-K | Stáhnout | |
| 2024-08-12 01:00:00 | 8-K | Stáhnout | |
| 2024-08-12 00:00:00 | 8-K | Stáhnout | |
| 2024-06-14 01:00:00 | 8-K | Stáhnout | |
| 2024-06-14 00:00:00 | 8-K | Stáhnout | |
| 2024-05-16 01:00:00 | 8-K | Stáhnout | |
| 2024-05-16 00:00:00 | 8-K | Stáhnout | |
| 2024-05-14 01:00:00 | 8-K | Stáhnout | |
| 2024-05-14 01:00:00 | 10-Q | Stáhnout | |
| 2024-05-14 00:00:00 | 8-K | Stáhnout | |
| 2024-05-14 00:00:00 | 10-Q | Stáhnout | |
| 2024-03-13 00:00:00 | 8-K | Stáhnout | |
| 2024-03-13 00:00:00 | 10-K | Stáhnout | |
| 2024-03-12 23:00:00 | 8-K | Stáhnout | |
| 2024-03-12 23:00:00 | 10-K | Stáhnout | |
| 2024-01-04 00:00:00 | 8-K | Stáhnout | |
| 2024-01-03 23:00:00 | 8-K | Stáhnout | |
| 2023-11-08 00:00:00 | 8-K | Stáhnout | |
| 2023-11-08 00:00:00 | 10-Q | Stáhnout | |
| 2023-11-07 23:00:00 | 8-K | Stáhnout | |
| 2023-11-07 23:00:00 | 10-Q | Stáhnout | |
| 2023-09-20 01:00:00 | 8-K | Stáhnout | |
| 2023-09-20 00:00:00 | 8-K | Stáhnout | |
| 2023-08-10 01:00:00 | 8-K | Stáhnout | |
| 2023-08-10 01:00:00 | 10-Q | Stáhnout | |
| 2023-08-10 00:00:00 | 8-K | Stáhnout | |
| 2023-08-10 00:00:00 | 10-Q | Stáhnout | |
| 2023-06-08 01:00:00 | 8-K | Stáhnout | |
| 2023-06-08 00:00:00 | 8-K | Stáhnout | |
| 2023-06-07 01:00:00 | 8-K | Stáhnout | |
| 2023-06-07 00:00:00 | 8-K | Stáhnout | |
| 2023-05-10 01:00:00 | 8-K | Stáhnout | |
| 2023-05-10 01:00:00 | 10-Q | Stáhnout | |
| 2023-05-10 00:00:00 | 8-K | Stáhnout | |
| 2023-05-10 00:00:00 | 10-Q | Stáhnout | |
| 2023-03-22 00:00:00 | 8-K | Stáhnout | |
| 2023-03-22 00:00:00 | 10-K | Stáhnout | |
| 2023-03-21 23:00:00 | 8-K | Stáhnout | |
| 2023-03-21 23:00:00 | 10-K | Stáhnout | |
| 2023-03-10 00:00:00 | 8-K | Stáhnout | |
| 2023-03-09 23:00:00 | 8-K | Stáhnout | |
| 2022-12-19 00:00:00 | 8-K | Stáhnout | |
| 2022-12-18 23:00:00 | 8-K | Stáhnout | |
| 2022-11-23 00:00:00 | 8-K | Stáhnout | |
| 2022-11-22 23:00:00 | 8-K | Stáhnout | |
| 2022-11-09 00:00:00 | 8-K | Stáhnout | |
| 2022-11-09 00:00:00 | 10-Q | Stáhnout | |
| 2022-11-08 23:00:00 | 8-K | Stáhnout | |
| 2022-11-08 23:00:00 | 10-Q | Stáhnout | |
| 2022-10-14 01:00:00 | 8-K | Stáhnout | |
| 2022-10-14 00:00:00 | 8-K | Stáhnout | |
| 2022-08-09 01:00:00 | 8-K | Stáhnout | |
| 2022-08-09 01:00:00 | 10-Q | Stáhnout | |
| 2022-08-09 00:00:00 | 8-K | Stáhnout | |
| 2022-08-09 00:00:00 | 10-Q | Stáhnout | |
| 2022-07-12 01:00:00 | 8-K | Stáhnout | |
| 2022-07-12 00:00:00 | 8-K | Stáhnout | |
| 2022-06-15 01:00:00 | 8-K | Stáhnout | |
| 2022-06-15 00:00:00 | 8-K | Stáhnout | |
| 2022-05-16 01:00:00 | 8-K | Stáhnout | |
| 2022-05-16 01:00:00 | 10-Q | Stáhnout | |
| 2022-05-16 00:00:00 | 8-K | Stáhnout | |
| 2022-05-16 00:00:00 | 10-Q | Stáhnout | |
| 2022-04-12 01:00:00 | 8-K | Stáhnout | |
| 2022-04-12 00:00:00 | 8-K | Stáhnout | |
| 2022-03-22 00:00:00 | 8-K | Stáhnout | |
| 2022-03-22 00:00:00 | 10-K | Stáhnout | |
| 2022-03-21 23:00:00 | 8-K | Stáhnout | |
| 2022-03-21 23:00:00 | 10-K | Stáhnout | |
| 2021-11-09 00:00:00 | 8-K | Stáhnout | |
| 2021-11-09 00:00:00 | 10-Q | Stáhnout | |
| 2021-11-08 23:00:00 | 8-K | Stáhnout | |
| 2021-11-08 23:00:00 | 10-Q | Stáhnout | |
| 2021-09-10 01:00:00 | 8-K | Stáhnout | |
| 2021-09-10 00:00:00 | 8-K | Stáhnout | |
| 2021-08-11 01:00:00 | 8-K | Stáhnout | |
| 2021-08-11 01:00:00 | 10-Q | Stáhnout | |
| 2021-08-11 00:00:00 | 8-K | Stáhnout | |
| 2021-08-11 00:00:00 | 10-Q | Stáhnout | |
| 2021-07-14 01:00:00 | 8-K | Stáhnout | |
| 2021-07-14 00:00:00 | 8-K | Stáhnout | |
| 2021-07-01 01:00:00 | 8-K | Stáhnout | |
| 2021-07-01 00:00:00 | 8-K | Stáhnout | |
| 2021-06-09 01:00:00 | 8-K | Stáhnout | |
| 2021-06-09 00:00:00 | 8-K | Stáhnout | |
| 2021-05-12 01:00:00 | 8-K | Stáhnout | |
| 2021-05-12 01:00:00 | 10-Q | Stáhnout | |
| 2021-05-12 00:00:00 | 8-K | Stáhnout | |
| 2021-05-12 00:00:00 | 10-Q | Stáhnout | |
| 2021-03-23 00:00:00 | 8-K | Stáhnout | |
| 2021-03-23 00:00:00 | 10-K | Stáhnout | |
| 2021-03-22 23:00:00 | 8-K | Stáhnout | |
| 2021-03-22 23:00:00 | 10-K | Stáhnout | |
| 2021-03-12 00:00:00 | 8-K | Stáhnout | |
| 2021-03-11 23:00:00 | 8-K | Stáhnout | |
| 2021-02-23 00:00:00 | 8-K | Stáhnout | |
| 2021-02-22 23:00:00 | 8-K | Stáhnout | |
| 2021-02-17 00:00:00 | 8-K | Stáhnout | |
| 2021-02-16 23:00:00 | 8-K | Stáhnout | |
| 2020-12-07 00:00:00 | 8-K | Stáhnout | |
| 2020-12-06 23:00:00 | 8-K | Stáhnout | |
| 2020-12-04 00:00:00 | 8-K | Stáhnout | |
| 2020-12-03 23:00:00 | 8-K | Stáhnout | |
| 2020-11-16 00:00:00 | 8-K | Stáhnout | |
| 2020-11-16 00:00:00 | 10-Q | Stáhnout | |
| 2020-11-15 23:00:00 | 8-K | Stáhnout | |
| 2020-11-15 23:00:00 | 10-Q | Stáhnout | |
| 2020-08-20 01:00:00 | 8-K | Stáhnout | |
| 2020-08-20 00:00:00 | 8-K | Stáhnout | |
| 2020-08-13 01:00:00 | 8-K | Stáhnout | |
| 2020-08-13 01:00:00 | 10-Q | Stáhnout | |
| 2020-08-13 00:00:00 | 8-K | Stáhnout | |
| 2020-08-13 00:00:00 | 10-Q | Stáhnout | |
| 2020-07-27 01:00:00 | 8-K | Stáhnout | |
| 2020-07-27 00:00:00 | 8-K | Stáhnout | |
| 2020-07-10 01:00:00 | 8-K | Stáhnout | |
| 2020-07-10 00:00:00 | 8-K | Stáhnout | |
| 2020-06-10 01:00:00 | 8-K | Stáhnout | |
| 2020-06-10 00:00:00 | 8-K | Stáhnout | |
| 2020-05-22 01:00:00 | 8-K | Stáhnout | |
| 2020-05-22 00:00:00 | 8-K | Stáhnout | |
| 2020-05-12 01:00:00 | 8-K | Stáhnout | |
| 2020-05-12 01:00:00 | 10-Q | Stáhnout | |
| 2020-05-12 00:00:00 | 8-K | Stáhnout | |
| 2020-05-12 00:00:00 | 10-Q | Stáhnout | |
| 2020-03-24 00:00:00 | 8-K | Stáhnout | |
| 2020-03-24 00:00:00 | 10-K | Stáhnout | |
| 2020-03-23 23:00:00 | 8-K | Stáhnout | |
| 2020-03-23 23:00:00 | 10-K | Stáhnout | |
| 2019-11-12 00:00:00 | 8-K | Stáhnout | |
| 2019-11-12 00:00:00 | 10-Q | Stáhnout | |
| 2019-11-11 23:00:00 | 8-K | Stáhnout | |
| 2019-11-11 23:00:00 | 10-Q | Stáhnout | |
| 2019-09-18 01:00:00 | 8-K | Stáhnout | |
| 2019-09-18 00:00:00 | 8-K | Stáhnout | |
| 2019-08-23 01:00:00 | 8-K | Stáhnout | |
| 2019-08-23 00:00:00 | 8-K | Stáhnout | |
| 2019-08-07 01:00:00 | 8-K | Stáhnout | |
| 2019-08-07 01:00:00 | 10-Q | Stáhnout | |
| 2019-08-07 00:00:00 | 8-K | Stáhnout | |
| 2019-08-07 00:00:00 | 10-Q | Stáhnout | |
| 2019-06-20 01:00:00 | 8-K | Stáhnout | |
| 2019-06-20 00:00:00 | 8-K | Stáhnout | |
| 2019-06-04 01:00:00 | 8-K | Stáhnout | |
| 2019-06-04 00:00:00 | 8-K | Stáhnout | |
| 2019-05-08 01:00:00 | 8-K | Stáhnout | |
| 2019-05-08 01:00:00 | 10-Q | Stáhnout | |
| 2019-05-08 00:00:00 | 8-K | Stáhnout | |
| 2019-05-08 00:00:00 | 10-Q | Stáhnout | |
| 2019-03-21 00:00:00 | 8-K | Stáhnout | |
| 2019-03-21 00:00:00 | 10-K | Stáhnout | |
| 2019-03-20 23:00:00 | 8-K | Stáhnout | |
| 2019-03-20 23:00:00 | 10-K | Stáhnout | |
| 2019-01-29 00:00:00 | 8-K | Stáhnout | |
| 2019-01-28 23:00:00 | 8-K | Stáhnout | |
| 2019-01-03 00:00:00 | 8-K | Stáhnout | |
| 2019-01-02 23:00:00 | 8-K | Stáhnout | |
| 2018-11-27 00:00:00 | 8-K | Stáhnout | |
| 2018-11-26 23:00:00 | 8-K | Stáhnout | |
| 2018-11-13 00:00:00 | 8-K | Stáhnout | |
| 2018-11-13 00:00:00 | 10-Q | Stáhnout | |
| 2018-11-12 23:00:00 | 8-K | Stáhnout | |
| 2018-11-12 23:00:00 | 10-Q | Stáhnout | |
| 2018-10-22 01:00:00 | 8-K | Stáhnout | |
| 2018-10-22 00:00:00 | 8-K | Stáhnout | |
| 2018-10-18 01:00:00 | 8-K | Stáhnout | |
| 2018-10-18 00:00:00 | 8-K | Stáhnout | |
| 2018-09-07 01:00:00 | 8-K | Stáhnout | |
| 2018-09-07 00:00:00 | 8-K | Stáhnout | |
| 2018-08-14 01:00:00 | 8-K | Stáhnout | |
| 2018-08-14 01:00:00 | 10-Q | Stáhnout | |
| 2018-08-14 00:00:00 | 8-K | Stáhnout | |
| 2018-08-14 00:00:00 | 10-Q | Stáhnout | |
| 2018-07-24 01:00:00 | 8-K | Stáhnout | |
| 2018-07-24 00:00:00 | 8-K | Stáhnout | |
| 2018-06-20 01:00:00 | 8-K | Stáhnout | |
| 2018-06-20 00:00:00 | 8-K | Stáhnout | |
| 2018-06-15 01:00:00 | 8-K | Stáhnout | |
| 2018-06-15 00:00:00 | 8-K | Stáhnout | |
| 2018-06-13 01:00:00 | 8-K | Stáhnout | |
| 2018-06-13 00:00:00 | 8-K | Stáhnout | |
| 2018-05-31 01:00:00 | 8-K | Stáhnout | |
| 2018-05-31 00:00:00 | 8-K | Stáhnout | |
| 2018-05-07 01:00:00 | 8-K | Stáhnout | |
| 2018-05-07 01:00:00 | 10-Q | Stáhnout | |
| 2018-05-07 00:00:00 | 8-K | Stáhnout | |
| 2018-05-07 00:00:00 | 10-Q | Stáhnout | |
| 2018-03-21 00:00:00 | 8-K | Stáhnout | |
| 2018-03-21 00:00:00 | 10-K | Stáhnout | |
| 2018-03-20 23:00:00 | 8-K | Stáhnout | |
| 2018-03-20 23:00:00 | 10-K | Stáhnout | |
| 2017-11-21 00:00:00 | 8-K | Stáhnout | |
| 2017-11-20 23:00:00 | 8-K | Stáhnout |
